Business Wire08.04.20
Tandem Diabetes Care Inc., an insulin delivery and diabetes technology company, has appointed Kathleen McGroddy-Goetz, Ph.D., as an independent member of its Board of Directors. Dr. McGroddy-Goetz has extensive experience commercializing pioneering technologies spanning from microelectronics through cloud, advanced data analytics, AI, hardware, software, and middleware with an emphasis on healthcare and life sciences applications.
“We welcome Kathy to our Board of Directors at this important next stage in Tandem’s evolution,” said John Sheridan, president and CEO, Tandem Diabetes Care. “She is a leader in creating transformative healthcare and life sciences solutions, which brings tremendous value to our Company as we advance our mission to improve the lives of people with diabetes.”
Dr. McGroddy-Goetz has more than 25 years of experience leading global teams across business development, strategy, research and development, and product management.
She is currently the global head of Strategic Partnerships at Medidata Solutions, a Dassault Systemès Company, and vice president of Strategy, Partnerships and Alliances at Medidata’s Acorn AI subsidiary.
Prior to her current positions, Dr. McGroddy-Goetz was vice president of Global Strategic Partnerships and Solutions at IBM, where she played a critical role in creating and launching Watson Health.
Dr. McGroddy-Goetz earned a bachelor of science degree in physics from SUNY Binghamton and a Ph.D. in molecular biophysics from Cornell University.
“We welcome Kathy to our Board of Directors at this important next stage in Tandem’s evolution,” said John Sheridan, president and CEO, Tandem Diabetes Care. “She is a leader in creating transformative healthcare and life sciences solutions, which brings tremendous value to our Company as we advance our mission to improve the lives of people with diabetes.”
Dr. McGroddy-Goetz has more than 25 years of experience leading global teams across business development, strategy, research and development, and product management.
She is currently the global head of Strategic Partnerships at Medidata Solutions, a Dassault Systemès Company, and vice president of Strategy, Partnerships and Alliances at Medidata’s Acorn AI subsidiary.
Prior to her current positions, Dr. McGroddy-Goetz was vice president of Global Strategic Partnerships and Solutions at IBM, where she played a critical role in creating and launching Watson Health.
Dr. McGroddy-Goetz earned a bachelor of science degree in physics from SUNY Binghamton and a Ph.D. in molecular biophysics from Cornell University.